CARTRIDGE DEVICE FOR A MEASURING SYSTEM FOR MEASURING VISCOELASTIC CHARACTERISTICS OF A SAMPLE LIQUID, A CORRESPONDING MEASURING SYSTEM, AND A CORRESPONDING METHOD
20190353673 ยท 2019-11-21
Assignee
Inventors
Cpc classification
B01L2300/0636
PERFORMING OPERATIONS; TRANSPORTING
B01L2300/0627
PERFORMING OPERATIONS; TRANSPORTING
B01L2200/10
PERFORMING OPERATIONS; TRANSPORTING
G01N11/00
PHYSICS
B01L3/502
PERFORMING OPERATIONS; TRANSPORTING
G01N33/86
PHYSICS
B01L2400/0475
PERFORMING OPERATIONS; TRANSPORTING
B01L2300/0861
PERFORMING OPERATIONS; TRANSPORTING
B01L3/52
PERFORMING OPERATIONS; TRANSPORTING
B01L2300/087
PERFORMING OPERATIONS; TRANSPORTING
International classification
G01N33/86
PHYSICS
B01L3/00
PERFORMING OPERATIONS; TRANSPORTING
G01N11/00
PHYSICS
Abstract
The present invention is directed to a cartridge device for a measuring system for measuring viscoelastic characteristics of a sample liquid, in particular a blood sample, comprising a cartridge body having at least one measurement cavity formed therein and having at least one probe element arranged in said at least one measurement cavity for performing a test on said sample liquid; and a cover being attachable on said cartridge body; wherein said cover covers at least partially said at least one measurement cavity and forms a retaining element for retaining said probe element in a predetermined position within said at least one measurement cavity. The invention is directed to a measurement system and a method for measuring viscoelastic characteristics of a sample liquid.
Claims
1. An apparatus for evaluation of hemostasis, comprising: a housing that is configured to couple to a system, wherein the system comprises one or more transducers for each of a plurality of test chambers, wherein the system comprises control apparatus to direct the one or more transducers associated with each of the plurality of test chambers in the interrogation of the test sample to determine at least one viscoelastic property of the test sample; the plurality of test chambers, including a first test chamber, a second test chamber, and a third test chamber, that are each at least partially defined by the housing; and a fluid pathway having an inlet, defined by the housing, and from which an external vessel establishes fluid communication, to receive a test sample, wherein the fluid pathway is in fluid communication with the first test chamber, the second test chamber, and the third test chamber to deliver the test sample, or a portion thereof, to the first test chamber, the second test chamber, and the third test chamber, wherein each of the plurality of test chambers comprises a reagent or combination of reagents, and wherein each of the plurality of test chambers, including the first, second, and third test chambers, is configured to receive, via the fluid pathway, blood of a test sample to be interrogated to determine a plurality of hemostatic parameters; wherein the first test chamber comprises a first reagent or a first combination of reagents that interact with the blood received therein, wherein the first reagent, or a reagent included in the first combination of reagents, is configured to activate coagulation via extrinsic or intrinsic pathway; wherein the second test chamber comprises a second combination of reagents that interact with blood of the test sample received therein, wherein the second combination of reagents includes i) a reagent, or a combination of reagents, configured to activate coagulation via the extrinsic or intrinsic pathway and ii) a reagent, or a combination of reagents, configured to inhibit platelet contraction; and wherein the third test chambers comprises a third reagent or a third combination of reagents that interact with the blood received therein, wherein the third reagent, or a reagent included in the third combination of reagents, is configured to activate coagulation via the extrinsic or intrinsic pathway.
2. The apparatus of claim 1, wherein the interrogation to determine the hemostatic parameter of the blood is based on a change in clot mechanical properties.
3. The apparatus of claim 1, wherein at least one of the first reagent, the second combination of reagents, and the third reagent is stored within the housing in solid form prior to interacting with the test samples.
4. The apparatus of claim 1, wherein the housing forms a cartridge comprising the plurality of test chambers and the fluid pathway.
5. The apparatus of claim 4, wherein the cartridge defines at least a portion of the fluid pathway.
6. The apparatus of claim 4, wherein the fluid pathway further comprises a channel in fluid communication with at least one test chamber, and wherein sample delivered from the channel into the test chamber results in mixing of at least a portion of the sample and the reagent within the test chamber.
7. The apparatus of claim 4, wherein the cartridge is disposable.
8. The apparatus of claim 1, wherein the evaluation of hemostasis comprises an assessment of components of hemostasis that include combined effects of coagulation, platelets, and fibrinolysis.
9. The apparatus of claim 1, wherein the evaluation of hemostasis comprises an assessment of components of hemostasis that include plasma coagulation factors, platelets, fibrinogen, and fibrinolytic factors of the plasma.
10. The apparatus of claim 1, wherein the one or more transducers include a light emitter and detector.
11. The apparatus of claim 1, wherein at least three measurements are performed in parallel within the plurality of test chambers using a combination of agonists and antagonists of hemostasis in at least one of the three test chambers.
12. The apparatus of claim 1, wherein the first reagent or the first combination of reagents are mixed with the test sample in a portion of the fluid pathway prior to being delivered to the first test chamber.
13. The apparatus of claim 1, wherein the one or more transducers can interrogate viscoelastic properties of the test samples within the plurality of test chambers based on induced displacement of the test sample produced by the one or more transducers.
14. The apparatus of claim 1, wherein the first reagent or first combination of reagents is INTEM or EXTEM and wherein the second combination of reagents is FIBTEM.
15. A system for evaluation of hemostasis comprising: a plurality of test chambers, including a first test chamber and a second test chamber, wherein each of the plurality of test chambers comprises a reagent or combination of reagents, and wherein each of the plurality of test chambers is configured to receive blood of a test sample and to be interrogated to determine a hemostatic parameter of the blood received therein; one or more transducers for transmitting energy into one or more test chamber and for receiving reflected energy from the chamber and the sample therein; and control apparatus configured to determine the hemostatic parameters from signals from the one or more transducers and to perform at least three measurements in parallel; wherein the first test chamber comprises a first reagent or a first combination of reagents that interact with the blood of the test sample received therein, wherein the first reagent, or at least one reagent included in the first combination of reagents, is an activator of coagulation; and wherein the second test chamber comprises a second combination of reagents that interact with blood of the test sample received therein, the second combination of reagents including an activator of coagulation and a reagent, or a combination of reagents, configured to cause a reduction in measurable changes in clot mechanical properties of the test sample when the test sample is interrogated by the one or more transducers.
16. The system of claim 15, wherein the clot mechanical properties comprises one or more viscoelastic properties of the test sample.
17. The system of claim 15, wherein the control apparatus is configured to determine a curve associated with a viscoelastic property of the blood of each test sample, the curve being generated from the interrogation as a function of time.
18. The system of claim 15, wherein the hemostasis parameters are selected from the group consisting of clotting time, clot formation rate, clot firmness, maximum clot firmness, clot formation rate and time to lysis.
19. The system of claim 15, wherein the control apparatus is configured to determine at least one parameter assessing the intrinsic pathway, the extrinsic pathway, platelet function, fibrinogen and/or lysis.
20. The system of claim 15, wherein the control apparatus is configured to determine at least one parameter from the group consisting of a clotting time for extrinsic activation or intrinsic activation, a comparison of clot firmness for activated coagulation tests with and without a thrombocyte suppression and time to lysis for extrinsic activation.
21. The system of claim 15, wherein at least one of the first reagent or the first combination of reagents and the second combination of reagents is provided in solid form prior to interacting with the test samples.
22. The system of claim 15, wherein the plurality of test chambers and a fluid pathway having an inlet for receiving a test sample form a part of a cartridge, wherein the fluid pathway is in fluid communication with at least one test chamber to deliver the test sample, or a portion thereof, to one or more of the test chambers.
23. The system of claim 15, wherein the first reagent or the first combination of reagents are mixed with the test chamber in a part of a fluid pathway prior to being delivered to the first test chamber.
24. The system of claim 15, wherein the plurality of test chambers form a part of a single use disposable cartridge.
25. The system of claim 24, wherein the single use disposable cartridge is configured to be securely received and held in position relative to a measuring system.
26. The system of claim 15, wherein a measuring system is configured to securely receive and position the plurality the test chambers in a predefined orientation.
27. The system of claim 15, wherein the system is capable of assessing components of hemostasis that include plasma coagulation factors, platelets, fibrinogen, and fibrinolytic factors of the plasma.
28. The system of claim 15, wherein the one or more transducers include a light emitter and detector.
29. The system of claim 15, wherein the system is capable of assessing components of hemostasis that include combined effects of coagulation, platelets, and fibrinolysis.
30. The system of claim 15, wherein the control apparatus is configured to determine the hemostatic parameters based on signals generated from induced displacement of the test sample produced by the one or more transducers.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
[0060] The figures are showing the following:
[0061]
[0062]
[0063]
[0064]
[0065]
[0066]
[0067]
[0068]
[0069]
[0070]
[0071]
[0072]
[0073]
[0074]
[0075]
[0076]
[0077]
[0078]
[0079]
[0080]
[0081]
[0082]
[0083]
[0084]
DESCRIPTION OF EXEMPLARY EMBODIMENTS
[0085] Parts and components having same functions are depicted with same references.
[0086] Prior to a detailed description of the preferred embodiments the basic features and a basic practical implementation are summoned as follows. All embodiments refer to a cartridge device 50 (see
[0087] A first embodiment of a cartridge device 50 of the invention will be described with reference to
[0088] In this embodiment the receiving cavity 16 consists of a cavity within the cartridge device 50. The sample liquid 1 can be applied by means of a syringe, pipette etc, e.g. through a self sealing cap shown as a receiving cavity cover 33a in
[0089] In an alternative embodiment the reagent cavity 19 is integral formed with the pump means 18 and/or with the measurement cavity 20 and/or with the ductwork. The transport of the sample liquid 1 can be controlled by said control apparatus.
[0090]
[0091] It is apparent to a person skilled in the art that in order to achieve a maximum benefit for a user different types of tests can be combined in one cartridge device 50.
[0092] In a preferred embodiment the cartridge device 50 comprises four arrangements of
[0093] Regarding e.g. blood coagulation there are different reagents available which activate or suppress different parts of the coagulation cascade. Pentapharm GmbH (Munich, Germany) for example amongst others provide tests for intrinsic and extrinsic activation of a blood sample (INTEM or EXTEM respectively), and also a test for extrinsic activation in which the thrombocyte function is suppressed by administration of cytochalasin D (FIBTEM). It is state of the art that it is possible by wise combination of such tests to be able to determine very precisely at which point within the coagulation cascade a problem occurs. This is of great importance in order to determine a proper medication. By comparison of the results on an EXTEM test of a pathologic sample to those of a FIBTEM test of the same sample it is possible to e.g. precisely determine if a coagulation disorder results from lack of fibrinogen or a malfunction of platelets. Generally, there are different typical medical scenarios in which coagulation disorders are very likely to occur. For example coagulation disorders occurring during liver transplantation are merely caused by lack of certain coagulation factors etc., while coagulation disorders during open heart surgery are most likely due to the influence of heparin. This means basically that different medical settings require different coagulation tests. Referring to
[0094] It is important to note that the cartridge devices 50 of the described embodiments are suitable for different diagnostic tests like thromboelastometry, thromboelastography, platelet aggregometry and others. Depending on which type of test or tests the cartridge device 50 is designed for, there are different additional parts required which interact with the sample during measurement and/or an external control apparatus. Possible adaptations for thromboelastometry and platelet aggregometry are described below.
[0095]
[0096] The probe element 22 comprises the probe pin 3 (see
[0097] The probe element 22 is arranged in the measurement cavity 20 of the cartridge body 30 of the cartridge device 50 as shown in
[0098] During attaching the cartridge device 50 to the measuring system 40 (see also
[0099] It is also possible to insert the insert section 6a of the shaft 6 into the connector section 26 of the probe element 22 and push the probe element 22 down until its bottom contacts the bottom of the measurement cavity 20, 20 ensuring that the insert section 6a is completely inserted into the connector section 26. Then the shaft 6 will be moved up into the measuring resp. working position of the probe element 22 as shown in
[0100]
[0101] Now a third embodiment of the cartridge device 50 will be described with reference to
[0102]
[0103] The cartridge device 50 of this example is equipped with the ductwork 13 and 15. The ducts are formed with an diameter of approximately 1 mm in this embodiment. The ductwork requires that the cartridge device 50 comprises two parts: the cartridge body 30 and the cover 31, which are glued or welded together to obtain a leak-proof device. The cartridge body 30 is relative rigid and the cover 31 is formed as an elastic part. So it is possible to integrate the pump means 18 into the cover 31. Moreover, the cover 31 covers the receiving cavity 16 with the receiving cavity cover 33a and forms a type of liner wall 33 and a separation wall 34 forming an inlet for the inlet duct 13 within the receiving cavity 16. The receiving cavity cover 33a might act as a self seal for injection of a sample liquid 1 by a syringe for example. The cover 31 forms top parts of the ductwork 13 an 15 and a cover of the measurement cavity 20 (see also
[0104] In this embodiment a reagent cavity 19, 19 is formed, e.g. by sections of the ductwork or/and the pump means 18, 18 in which the reagents can be stored resp. deposited, especially on the pump cavity bottom 36a, for example.
[0105] The pump means 18 will now be described with reference to
[0106]
[0107] In this example the pump cavity 36 is connected to the inlet duct 13 via an inlet valve 37 and to the outlet valve via an outlet valve 38. Actuation of the pump membrane 35 (shown in
[0108] An external force exerted on the pump membrane 35 increase the pressure within the pump cavity 36 and opens outlet valve 38 and closes inlet valve 37. Releasing the external force the elastic pump membrane 35 returns into the position shown in
[0109] Now the measuring system 40 according to the invention is described in an embodiment with reference to
[0110]
[0111] The measuring system 40 comprises an interface element 41 to which the cartridge device 50 is attached and fixed. The interface element 41 is shown in
[0112]
[0113] Thus it is possible to e.g. arrange a reagent receptacle 19b in a blister receptacle e.g. as shown in
[0114] It is also possible to insert reagent receptacles into provided cavities being connected to the ductwork. The reagents can be designed as globules with an appropriate diameter so that they cannot flow through openings into the ductwork before being dissolved by the sample liquid.
[0115]
LIST OF REFERENCE NUMERALS
[0116] 1 Sample liquid
[0117] 2 Cup
[0118] 3 Probe pin
[0119] 4 Torsion wire
[0120] 5 Rotation axis
[0121] 6 Shaft
[0122] 6a Insert section
[0123] 7 Bearing
[0124] 8 Mirror
[0125] 9 Spring
[0126] 10 Detecting means
[0127] 11 Base plate
[0128] 12 Cup holder
[0129] 13, 13 Inlet duct
[0130] 14, 14 Intermediate duct
[0131] 15, 15 Outlet duct
[0132] 16, 16 Receiving cavity
[0133] 17 Branch duct
[0134] 18, 18 Pump means
[0135] 19,19 Reagent cavity
[0136] 19a, 19a Regent cavity bottom
[0137] 19b Reagent receptacle
[0138] 20, 20 Measurement cavity
[0139] 21, 21 Reagent
[0140] 22, 22 Probe element
[0141] 23 Intermediate section
[0142] 24 Flange
[0143] 25 Fixing section
[0144] 26 Connector section
[0145] 27 Insertion guide
[0146] 28 Groove
[0147] 29 Dimple
[0148] 29a Nose
[0149] 30 Cartridge body
[0150] 31 Cover
[0151] 32 Fixing means
[0152] 32a Opening
[0153] 33 Wall
[0154] 33a Receiving cavity cover
[0155] 34 Separation wall
[0156] 35 Pump membrane
[0157] 36 Pump cavity
[0158] 36a Pump cavity bottom
[0159] 37 Inlet valve
[0160] 38 Outlet valve
[0161] 39 Flow direction
[0162] 40 Measuring system
[0163] 41 Interface element
[0164] 42 Pump access
[0165] 43 inlet opening
[0166] 44 Shaft passage
[0167] 44a Passage hole
[0168] 45 Reagent cover opening
[0169] 46 Retaining ring
[0170] 47 Frame
[0171] 48 Bottom foil
[0172] 49 Blister cover
[0173] 50 Cartridge device